✦ LIBER ✦

Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers

✍ Scribed by Nozomi Niitsu; Miyuki Hayama; Tadashi Yoshino; Shigeo Nakamura; Jun-Ichi Tamaru; Hirokazu Nakamine; Masataka Okamoto

Book ID: 108677216
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 206 KB
Volume: 153
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08634.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentre phase II study of CyclOBEAP

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohri; Yuki Hagiwara; Ken Tanae; Naoki Takahashi; Masami Bes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The R‐CHOP regimen has been found to improve the outcome of diffuse large B‐cell lymphoma (DLBCL). However, it does not provide a satisfactory treatment outcome in the high‐risk group. We previously administered the CyclOBEAP regimen to patients with DLBCL, and reported its safety and e

Multicenter phase II study of CyclOBEAP

Multicenter phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma

✍ Nozomi Niitsu; Masataka Okamoto; Mika Kohori; Sadao Aoki; Ikuo Miura; Masami Hir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

## Abstract We treated elderly patients (65–69 years) who had aggressive lymphoma with the CyclOBEAP regimen, and we studied the safety and efficacy of this treatment. The CyclOBEAP regimen was administered over a total period of 12 weeks. Doxorubicin 40 mg/m^2^ was given every 2 weeks in combinati

Multicenter phase II study of the CyclOB

Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma

✍ Nozomi Niitsu; Masataka Okamoto; Sadao Aoki; Hirokazu Okumura; Tadashi Yoshino; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 123 KB

Phase II study of the irinotecan (CPT-11

Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma

✍ Nozomi Niitsu; Mika Kohori; Masaaki Higashihara; Masami Bessho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Alemtuzumab plus CHOP as front-line chem

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

✍ Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Yoon Young Cho; Deok Hwan Yang; Je 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

Phase II study of the CPT-11, mitoxantro

Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohuri; Masaaki Higashihara; Masami Bessho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB